IM Cannabis Corp. (IMCC.CN)

1.3800 0.0000 (0.00%) At close: 03:35PM EDT

IM Cannabis Corp.

Kibbutz Glil Yam
Central District
Tel Aviv
Israel
972 5 44331111
https://www.imcannabis.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 283

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Marc Lustig M.B.A., M.Sc.	Exec. Chairman	590k	N/A	1974
Mr. Oren Shuster	CEO & Director	539.07k	N/A	N/A
Mr. Shai Shemesh	Chief Financial Officer	324.96k	N/A	N/A
Mr. Richard Balla	CEO & Director of German Operations – Adjupharm GmbH	410.6k	N/A	N/A
Advocate Yael Harrosh	Chief Legal & Operations Officer	N/A	N/A	N/A
Mr. Michael Ruscetta	Co-Head of North America & CEO of Trichome Financial Corp.	N/A	N/A	1970
Mr. Howard Steinberg C.F.A.	Co-Head of North America & CEO of TJAC	N/A	N/A	1966

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Corporate Governance

IM Cannabis Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.